Positive results in Phase 2 trial of treatment of C-difficile-associated diarrhea
Monday, November 3, 2008 - 10:49
in Health & Medicine
Medarex, Inc. and The Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) today announced that a Phase 2 trial of an anti-C. difficile antibody combination treatment in patients with C. difficile Associated Diarrhea (CDAD) successfully met its primary objective.
Read the whole article on Physorg
More from Physorg
Related
- Positive results in Phase 2 trial of treatment of C-difficile-associated diarrheaMon, 3 Nov 2008, 10:50:30 EST
- C. difficile and antibiotics not necessarily linkedTue, 7 Oct 2008, 3:28:46 EDT
- Budesonide is not beneficial for the treatment of diarrhea in metastatic melanoma patientsTue, 11 Aug 2009, 17:50:21 EDT
- First human gets new antibody aimed at rabies virusWed, 30 Sep 2009, 14:25:38 EDT
- First human gets new antibody aimed at hepatitis C virusThu, 6 Aug 2009, 11:36:22 EDT